These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9723383)

  • 1. Cardiovascular complications after renal transplantation.
    Aker S; Ivens K; Guo Z; Grabensee B; Heering P
    Transplant Proc; 1998 Aug; 30(5):2039-42. PubMed ID: 9723383
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevalence evolution and impact of cardiovascular risk factors on allograft and renal transplant patient survival.
    Díaz JM; Gich I; Bonfill X; Solà R; Guirado L; Facundo C; Sainz Z; Puig T; Silva I; Ballarín J
    Transplant Proc; 2009; 41(6):2151-5. PubMed ID: 19715859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Triglycerides, apo C3 and Lp B:C3 and cardiovascular risk in type II diabetes.
    Gervaise N; Garrigue MA; Lasfargues G; Lecomte P
    Diabetologia; 2000 Jun; 43(6):703-8. PubMed ID: 10907114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dilemma: maintenance therapy enhances sclerogenic risk profile.
    Jacobs U; Klein B; Miersch WD; Molitor D; Klehr HU
    Transplant Proc; 1996 Dec; 28(6):3227-30. PubMed ID: 8962249
    [No Abstract]   [Full Text] [Related]  

  • 5. Epidemiology of cardiovascular diseases: current perspectives.
    Kuller LH
    Am J Epidemiol; 1976 Oct; 104(4):425-96. PubMed ID: 788505
    [No Abstract]   [Full Text] [Related]  

  • 6. Control of risk factors for cardiovascular disease in long-term renal transplant recipients.
    First MR; Peddi VR; Weiskittel P; Woodle ES
    Transplant Proc; 2001; 33(7-8):3674-5. PubMed ID: 11750563
    [No Abstract]   [Full Text] [Related]  

  • 7. Incidence of cardiovascular risk factors and complications before and after kidney transplantation.
    Fazelzadeh A; Mehdizadeh A; Ostovan MA; Raiss-Jalali GA
    Transplant Proc; 2006 Mar; 38(2):506-8. PubMed ID: 16549161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term results and complications of living related kidney transplantation in a single center.
    Yoshimura N; Oka T; Nakane Y; Aikawa I; Okamoto M; Akioka K; Nakamura K; Ushigome H; Kadotani Y; Ohmori Y
    Transplant Proc; 2002 Aug; 34(5):1675-7. PubMed ID: 12176531
    [No Abstract]   [Full Text] [Related]  

  • 9. No clinical evidence of hyperlipidemia as a risk factor for chronic renal allograft failure.
    Hillebrand GF; Schlosser S; Schneeberger H; Lorenz B; Zanker B; Samtleben W; Land W
    Transplant Proc; 1999; 31(1-2):1391-2. PubMed ID: 10083615
    [No Abstract]   [Full Text] [Related]  

  • 10. Abnormal lipid and lipoprotein profiles following renal transplantation.
    Moore R; Thomas D; Morgan E; Wheeler D; Griffin P; Salaman J; Rees A
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1060-1. PubMed ID: 8442042
    [No Abstract]   [Full Text] [Related]  

  • 11. Risk factors for cardiovascular disease in patients with functioning kidney grafts.
    Lorenzetti M; Giannarelli R; Paleologo G; Rizzo G; Marchetti P; Coppelli A; Innocenti M; Rindi P; Carmellini M; Mosca F; Marselli L; Lencioni C; Di Cianni G; Navalesi R
    Transplant Proc; 1998 Aug; 30(5):2047. PubMed ID: 9723385
    [No Abstract]   [Full Text] [Related]  

  • 12. Role of ACE gene polymorphism on cardiovascular complications after renal transplantation.
    Hernández D; Linares J; Salido E; Cobo M; Rodríguez A; Lorenzo V; Jiménez A; González-Posada J; Torres A
    Transplant Proc; 2001; 33(7-8):3686-7. PubMed ID: 11750570
    [No Abstract]   [Full Text] [Related]  

  • 13. Considering death with function as a graft loss in kidney transplant recipients.
    West MS; Sutherland DE; Matas AJ
    Transplant Proc; 1997; 29(1-2):239. PubMed ID: 9122979
    [No Abstract]   [Full Text] [Related]  

  • 14. [Prevalence of cardiovascular risk factors in coronary heart disease patients with different low-density lipoprotein phenotypes].
    Slapikas R; Luksiene D; Slapikiene B; Babarskiene MR; Grybauskiene R; Linoniene L
    Medicina (Kaunas); 2005; 41(11):925-31. PubMed ID: 16333215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular and cerebrovascular disease in an elderly poor urban population.
    Ostfeld AM; Shekelle RB; Tufo HM; Wieland AM; Kilbridge JA; Drori J; Klawans H
    Am J Public Health; 1971 Jan; 61(1):19-29. PubMed ID: 5539847
    [No Abstract]   [Full Text] [Related]  

  • 16. Lipoproteins, cardiovascular disease, and death. The Framingham study.
    Gordon T; Kannel WB; Castelli WP; Dawber TR
    Arch Intern Med; 1981 Aug; 141(9):1128-31. PubMed ID: 7259370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pretransplant calcium levels have no predictive value for delayed graft function, long-term graft function, cardiovascular events, or graft and patient survival in renal transplantation.
    Krüger B; Schnitzbauer AA; Böger CA; Hoffmann U; Banas B; Farkas S; Schlitt HJ; Obed A; Krämer BK
    Transplant Proc; 2006 Apr; 38(3):697-700. PubMed ID: 16647448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of triglycerides in coronary artery disease: lessons from the Prospective Cardiovascular Münster Study.
    Assmann G; Schulte H
    Am J Cardiol; 1992 Dec; 70(19):10H-13H. PubMed ID: 1466311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of immunosuppressive regimen on cardiovascular risk factors in kidney transplant recipients.
    Boucher A; Masse M; Lauzon L; Morin M; Dandavino R
    Transplant Proc; 2002 Aug; 34(5):1799-802. PubMed ID: 12176582
    [No Abstract]   [Full Text] [Related]  

  • 20. Ambulatory blood pressure after renal transplantation.
    Fernández-Vega F; Tejada F; Baltar J; Laures A; Gómez E; Alvarez J
    Nephrol Dial Transplant; 2001; 16 Suppl 1():110-3. PubMed ID: 11369836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.